Seretide withdrawal increases airway inflammation in moderate COPD patients.
Borrill
Zoe
Z
Roy
Kay
K
Kolsum
Umme
U
Southworth
Tom
T
Vestbo
Jorgen
J
Singh
Dave
D
D000368:Aged; D000402:Airway Obstruction / Q000209:etiology*; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000009:adverse effects*; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000209:etiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
D000730:Androstadienes; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D000420:Albuterol